Novaphex 125mg/5mils powder for suspension

Novaphex Suspension is a pharmaceutical product that contains Cefalexin in a concentration of 125mg per 5 milliliters, presented as a powder for reconstitution into a suspension. Cefalexin is a cephalosporin antibiotic that is used to treat various bacterial infections.

Usage

Novaphex Suspension is indicated for the treatment of a wide range of bacterial infections caused by susceptible microorganisms. These may include respiratory tract infections, skin and soft tissue infections, urinary tract infections, otitis media, and other conditions where Cefalexin is deemed appropriate by a healthcare professional.

Dosage
The recommended dosage of Novaphex Suspension should be determined by a qualified healthcare provider based on the specific condition being treated, the severity of the infection, and the patient’s age and weight. It is crucial to follow the prescribed dosage and administration instructions provided by the healthcare professional or as indicated on the product label.

Side Effects
While Novaphex Suspension is generally well-tolerated, like any medication, it may cause side effects in some individuals. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Allergic reactions are possible but rare. If any unusual or severe side effects occur, it is essential to seek medical attention promptly.

Warnings

1. AllergiesPatients with known allergies to cephalosporin antibiotics or penicillins should avoid Novaphex Suspension.
2. Renal Impairment Caution is advised in patients with renal impairment, as dosage adjustments may be necessary based on the degree of kidney function.
3. Clostridium difficile-Associated Diarrhea The use of Novaphex Suspension may lead to the development of Clostridium difficile-associated diarrhea, which can range from mild to life-threatening. If persistent diarrhea occurs during or after treatment, medical attention should be sought.
4. Superinfection Prolonged use may result in the overgrowth of nonsusceptible organisms, leading to superinfection. Monitoring for superinfection and appropriate measures are recommended.

Patients are advised to inform their healthcare provider about all current medications, medical history, and any existing health conditions before starting Novaphex Suspension.

This description provides a general overview, and specific details should be obtained from a healthcare professional